Mile High Labs Raises $65MM to Purchase Mountains of Hemp
April 12th, 2019
BOULDER, Colo., April 12, 2019 /PRNewswire/ — Mile High Labs, the largest extractor of CBD in the world, achieved another historic financing event with the close of a $65MM term loan facility, one of the largest non-dilutive capital raises in the sector to date. The financing comes on the heels of the largest Series A equity raise in cannabis market history, completed during the fourth quarter of 2018.
“Following the signing of the Farm Bill in late 2018, we started seeing speculators take out significant portions of the available hemp supply. So we acted decisively to secure the single largest source of high-quality biomass available,” said Jon Hilley, CFO of Mile High Labs. “It is quite literally a mountain of hemp – millions of pounds – and this funding guarantees we can continue to meet the increasing demand for CBD from our customers.”
Jason Roth, CEO of Mile High Labs, added, “I want to take a moment to thank two groups who made this possible. The first is our farm partners who trust and believe in us – we greatly appreciate your support and hard work. The second is MGG Investment Group, an incredibly sharp group of investment professionals who worked with us at breakneck speed to get this deal done. MGG is one of the most thorough, thoughtful and commercially minded debt funds I’ve come across – they are great partners who understand our vision and want to support it.”
This non-dilutive deal bests most of the deals being done on the market today due to its low cost and speed of execution. Investor Danny Moses, best known for his portrayal in The Big Short, is an investor in Mile High Labs and also consulted with MGG on this financing.
“I was lucky enough to have met the Mile High Labs team last year and saw first-hand their drive to be the standard setter in the hemp extraction business,” said Moses. “This financing represents one of the lowest cost debt deals I’ve seen in this market and is representative of what can happen when you have a strong management team, a solid business plan and the vision to be the global leader in a sector with so much opportunity.”
“With this funding in place and our biomass supply secured, it’s time to put our heads down and continue to lead the way in CBD quality, safety and compliance,” continued Roth. “Most analysts believe CBD will be one of the largest consumer markets in the world. There will be many winners in the CBD market, and we expect to be one of the largest.”
For more information on Mile High Labs, please visit www.milehighlabs.com. For sales inquiries, please call 833.CBD.1011.
About Mile High Labs
Mile High Labs is an industrial-scale CBD ingredient manufacturer offering reliable delivery of bulk CBD and co-packing services to the world’s leading consumer brands. With an end-to-end GMP certified extraction facility and extensive network of contracted cultivators, Mile High Labs supplies high-quality, high-volume CBD orders year round. Mile High Labs extracts exclusively from industrial hemp flower material. To learn more about Mile High Labs, visit www.milehighlabs.com.
SOURCE Mile High Labs
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.